AICTE QUALITY IMPROVEMENT PROGRAMME CENTRE (PHARMACY)
Birla Institute of Technology
The Birla Institute of Technology was established in the year 1955 at Mesra, Ranchi, Jharkhand by the Philanthropist – Industrialist Late Sri B. M. Birla with a vision to establish a world – class institution to cater Engineering, Technology, Pharmaceutical, Management and other allied sciences. The Institute over last decades ranked well within top ten of the best Technical Universities of the country. The Institute offers Undergraduate, Postgraduate and Doctoral Programs.
Department of Pharmaceutical Sciences & Technology
The Department of Pharmaceutical Sciences & Technology, Birla Institute of Technology was established in 1972. The department caters the needs of Pharmaceutical Education in this part of the country having B. Pharm, M. Pharm. in six disciplines & Ph.D. programs recognized by PCI, AICTE, UGC and DST. The Department has been ranked 12th in the country by NIRF/MHRD, Govt. of India during 2016-17. Meritorious students (GPAT& Non GPAT ) from all over India can avail opportunities for higher education. The Department has been recognized as Q.I.P Center by AICTE since 2007. Department has been conducting Q.I.P programs for last 9 years which is very popular among pharmacy teachers. The Department has state of the art facilities for analysis of drugs with sophisticated instruments. It has Medicinal Plants Garden spread over in 10 acres of land. Department is actively involved in research encompassing Synthetic Chemistry, Natural Products’ Chemistry, Novel Drug Delivery System, Herbal Standardization and Formulations, besides Computer Aided Drug Design. Computational chemistry lab is rich with drug design and discovery software.
- Courses Offered and Number of Seats available:
- M. Pharm.(QIP Specializations: Pharmaceutics, Pharmaceutical Chemistry, Pharmacology and QARA) : 08
- Ph.D. in Pharmacy (QIP): 08
QUALITY IMPROVEMENT PROGRAMME 2020
A Green Therapeutic Approach Towards Cancer (Division of Pharmacognosy & Pharmacology)
7th Feb to 20th February, 2020
Application of Recent Innovations in Industry and Hospital Pharmacy (Division of Pharmaceutics)
21st February to 5th March, 2020
Application of Modern Analytical Techniques in Drug Discovery and Development (Division of Pharmaceutical Chemistry)
6th March to 19th June, 2020
Department of Pharmaceutical Sciences & Technology has been organizing the Quality Improvement Programme for last eight years. QIP 2017 would be ninth in this series. QIP 2017 comprise of three programmes of two weeks duration each.
1. Pharmacognosy & Pharmacology Division: Since the time immemorial, Natural products are considered to be the symbols of protection from diseases in comparison to the synthetic counterparts which are regarded little unsafe to human life. Although a large number of synthetic drugs have been added to our present pharmacopoeia, however, no system of medicine in the world has been able to ensure freedom from Cancer. Therefore, the search for innovative therapeutic constituents from plants is genuine and urgent. Plant-derived compounds like vinblastine, vincristine, the camptothecin derivatives, topotecan, irinotecan and etoposide have played an important role in the development of several clinically useful anti-cancer agents. Several promising new agents are under clinical developmental phases based on selective activity against cancer-related molecular targets, including flavopiridol and combretastin A4 phosphate, and some agents which failed in earlier clinical studies are also stimulating renewed interest. But large numbers of plants have still not been investigated thoroughly with regard to modern scientific perspectives. Thus, there is an insistent need for systematic phytochemical exploration of those plants using modern analytical & molecular pharmacology tools. During this QIP, different perspective of natural products will be discussed in depth with respect to Cancer Therapy
2. Pharmaceutical Chemistry Division: Drug development is a complex process, and added to it is the sophisticated new technologies and approaches to drug design, of which rational drug design is the epitome. A low success rate for investigational new drugs calls for improvement in drug discovery and development processes. Implementing knowledge driven drug development strategies founded on informative, powerful, and robust studies would greatly improve the drug discovery and development processes. This programme will cover the different aspects of Drug Discovery with special reference to basics, working principle, use of Molecular modeling & docking software/ validation besides the use of automated instruments likeUV/IR/NMR/MS/HPLC/GC/LC-MS/FESEM and other related techniques/ screening methods for identification of a clinical candidate as well.
3. Pharmaceutics Division: Drug delivery has emerged as an interdisciplinary and independent field of research which is gaining attention within pharmaceutical spheres. A targeted and safe drug delivery could improve the performance of therapeutics already in the market. In recent times, advent of various biotechniques (like biotechnology, bioengineering, gene therapy, etc.) has contributed immensely in evolution of drug delivery processes, ranging from novel therapeutic strategies to effective administration of biomolecules. This program aims to highlight these interlinks between modern drug development processes with contemporary bio techniques. Also, it would deliberate on latest trends in traditional drug delivery mechanisms and techniques.
Click here to download AICTE QIP 2020 Brochure
AICTE QIP 2018-19 Brochure
AICTE QIP 2017 Brochure
AICTE QIP 2015 Brochure
AICTE QIP 2014 Brochure
AICTE QIP 2013 Brochure
AICTE QIP 2012 Brochure
AICTE QIP 2011 Brochure
AICTE QIP 2010 Brochure
AICTE QIP 2009 Brochure
AICTE QIP 2008 Brochure